Clinical trial protocols have become increasingly intricate, with a surge in trials utilizing novel designs and continuous expansion in the volume and scope of research regulation. High-quality protocols are more likely to meet enrollment goals, address primary aims, and incorporate operational efficiencies. They can also be easier for less-experienced staff to implement. However, protocol development is time-consuming, and few investigators possess adequate training and experience. While centralized protocol development services can be highly effective, they are often cost-prohibitive. The NIH-funded CTSA Clinical and Translational Research-Launch (CTR-Launch) trial addresses these challenges by testing a novel concept – provision of FREE protocol writing support by a protocol writer to achieve high-quality protocols for investigator-initiated trials (IITs).
Closing the gap between science and practice is vital to improving care in our health systems and communities. The MICHR Dissemination & Implementation Science Catalyst Implementation Science Network (DISC-ISN) connects researchers to promote more innovative dissemination and implementation research, such as Dr. Cherie Conley’s research on integrating a weight loss peer support program in African American Faith Communities to decrease diabetes risk.
Are you a community partner who recently completed a project in collaboration with an academic researcher?
Are you an academic researcher who recently completed a study in collaboration with a community partner?
If so, we invite you to apply for the Michigan Institute for Clinical and Health Research (MICHR) Promoting Academics and Community Engagement (PACE) dissemination grant. The goal of PACE dissemination grants is to share Community-Engaged Research(CEnR) results back to the community.
On May 21, 2024, BRISP will present a conference on “Advancing Behavioral Science through AI and Digital Health.” The conference is designed for BSSR scientists to learn about AI and applications to their research. It brings together several AI experts on campus and features Keynote Speaker Amy Bucher, Ph.D., Chief Behavioral Officer at Lirio.
In Winter/spring 2024, MICHR will offer the popular Responsible Conduct of Research (RCR) for K Awardees, a seminar that is designed to meet the requirements of the NIH K-23, or any federal or non-federal career development grant.
“I would not be able to do this work without the support of common resources accumulated at MICHR. I value the work I am able to do at U-M and so much of it is enabled by the MICHR team. They are fundamental to getting good clinical research done at Michigan.”
The MICHR Expanded Access program is a fantastic resource. The Expanded Acccess process is pretty complicated, requiring communications with the FDA, the University institutional review board, the pharmaceutical company, and lots of documentation. Early in the COVID-19 epidemic, I worked with the TEAMSS staff to obtain remdesivir for some of our first patients at Michigan Medicine. All I had to do was decide on the drug and they pretty much took care of the rest. They were available after hours and on weekends. They ‘made it happen.’
I was finding research funding options to be very complicated and confusing, until I stumbled upon the MICHR webpage… cue ray of light and angels singing. The resources on this page were exactly what I had been searching for.